Hiroshi Maeda

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Lymph Node Metastasis

Top Venues

Biomacromolecules

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Makimoto, Jun Fang, Hiroshi Maeda
Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors. Cancers 13 (15) (2021)
Shin Takano, Waliul Islam, Kohji Nakazawa, Hiroshi Maeda, Kazuo Sakurai, Shota Fujii
Phosphorylcholine-Grafted Molecular Bottlebrush-Doxorubicin Conjugates: High Structural Stability, Long Circulation in Blood, and Efficient Anticancer Activity. Biomacromolecules 22 (3) (2020)
Hideaki Nakamura, Eva Koziolová, Petr Chytil, Tomas Etrych, Mamoru Haratake, Hiroshi Maeda
Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid. Molecular pharmaceutics 16 (8) (2019)